Cargando…
Application of insulin-like growth factor-1 in the treatment of inner ear disorders
Sensorineural hearing loss (SNHL) is considered an intractable disease, given that hair and supporting cells (HCs and SCs) of the postnatal mammalian cochlea are unable to regenerate. However, with progress in regenerative medicine in the 21st century, several innovative approaches for achieving reg...
Autores principales: | Yamamoto, Norio, Nakagawa, Takayuki, Ito, Juichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159992/ https://www.ncbi.nlm.nih.gov/pubmed/25309440 http://dx.doi.org/10.3389/fphar.2014.00208 |
Ejemplares similares
-
Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear
por: Hori, Ryusuke, et al.
Publicado: (2010) -
Analysis of Pharmacokinetics in the Cochlea of the Inner Ear
por: Sawamura, Seishiro, et al.
Publicado: (2021) -
Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss
por: Okano, Takayuki
Publicado: (2014) -
Gene and drug delivery system and potential treatment into inner ear for protection and regeneration
por: Kanzaki, Sho
Publicado: (2014) -
Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial
por: Nakagawa, Takayuki, et al.
Publicado: (2010)